D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge
Medicine
Germany
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 158 Citations 114,724 867 World Ranking 296 National Ranking 6
Best Scientists D-index 187 Citations 158,976 1,610 World Ranking 329 National Ranking 10

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

2022 - Research.com Medicine in Germany Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Disease

Stefan Schreiber mainly investigates Genetics, Internal medicine, Immunology, Genome-wide association study and Inflammatory bowel disease. His work in Single-nucleotide polymorphism, Locus, Allele, Gene and Candidate gene is related to Genetics. His Internal medicine research incorporates themes from Gastroenterology, Placebo and Surgery.

His studies in Immunology integrate themes in fields like Intestinal mucosa and Disease. Stefan Schreiber interconnects Genetic predisposition, Allele frequency, Quantitative trait locus, Genetic architecture and Genetic association in the investigation of issues within Genome-wide association study. In his work, Colitis and Bacteria is strongly intertwined with Ulcerative colitis, which is a subfield of Inflammatory bowel disease.

His most cited work include:

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial (3357 citations)
  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (3117 citations)
  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index (2348 citations)

What are the main themes of his work throughout his whole career to date?

Stefan Schreiber mainly focuses on Internal medicine, Genetics, Immunology, Gastroenterology and Crohn's disease. His study in the field of Ulcerative colitis and Disease is also linked to topics like In patient. His study in Genetics focuses on Single-nucleotide polymorphism, Genome-wide association study, Gene, Allele and Genetic association.

His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Haplotype and Locus. His study in Inflammatory bowel disease extends to Immunology with its themes. The Gastroenterology study combines topics in areas such as Placebo and Adverse effect.

He most often published in these fields:

  • Internal medicine (35.90%)
  • Genetics (24.72%)
  • Immunology (22.37%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (35.90%)
  • Crohn's disease (18.29%)
  • Gastroenterology (18.82%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Crohn's disease, Gastroenterology, Ulcerative colitis and Inflammatory bowel disease. As part of his studies on Internal medicine, Stefan Schreiber often connects relevant subjects like Placebo. His Crohn's disease study incorporates themes from Randomized controlled trial, Surgery, Adverse effect and Clinical trial.

His biological study spans a wide range of topics, including Moderate to severe, Antibody and Rheumatoid arthritis. Much of his study explores Ulcerative colitis relationship to Colitis. His Inflammatory bowel disease study frequently involves adjacent topics like Immunology.

Between 2016 and 2021, his most popular works were:

  • Analysis of shared heritability in common disorders of the brain (726 citations)
  • Pan-cancer analysis of whole genomes (538 citations)
  • Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis (537 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

His scientific interests lie mostly in Internal medicine, Crohn's disease, Gastroenterology, Ulcerative colitis and Inflammatory bowel disease. His Internal medicine course of study focuses on Placebo and Maintenance therapy. Stefan Schreiber has included themes like Surgery, Rheumatoid arthritis and Surrogate endpoint in his Crohn's disease study.

His Gastroenterology research integrates issues from Interleukin 6, Refractory and Phases of clinical research. The study incorporates disciplines such as Induction therapy, Colitis and Randomization in addition to Ulcerative colitis. His Inflammatory bowel disease study often links to related topics such as Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer.
The Lancet (2002)

4780 Citations

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr.
Nature (2012)

3671 Citations

Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

Mark S. Silverberg;Jack Satsangi;Tariq Ahmad;Ian D. R. Arnott.
Canadian Journal of Gastroenterology & Hepatology (2005)

3579 Citations

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda.
Nature Genetics (2010)

2864 Citations

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang.
Nature Genetics (2010)

2549 Citations

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Jean–Frédéric Colombel;William J. Sandborn;Paul Rutgeerts;Robert Enns.
Gastroenterology (2007)

2350 Citations

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)

2262 Citations

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

Jochen Hampe;Andre Franke;Philip Rosenstiel;Philip Rosenstiel;Andreas Till.
Nature Genetics (2007)

1935 Citations

Hundreds of variants clustered in genomic loci and biological pathways affect human height

Hana Lango Allen;Karol Estrada;Guillaume Lettre;Sonja I. Berndt.
Nature (2010)

1934 Citations

Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt.
web science (2012)

1870 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefan Schreiber

William J. Sandborn

William J. Sandborn

University of California, San Diego

Publications: 370

Severine Vermeire

Severine Vermeire

KU Leuven

Publications: 354

Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

University of Lorraine

Publications: 342

Jean-Frederic Colombel

Jean-Frederic Colombel

Icahn School of Medicine at Mount Sinai

Publications: 313

Hakon Hakonarson

Hakon Hakonarson

Children's Hospital of Philadelphia

Publications: 283

André G. Uitterlinden

André G. Uitterlinden

Erasmus University Rotterdam

Publications: 265

Albert Hofman

Albert Hofman

Harvard University

Publications: 260

Kari Stefansson

Kari Stefansson

deCODE Genetics (Iceland)

Publications: 252

Mark J. Daly

Mark J. Daly

University of Helsinki

Publications: 252

Silvio Danese

Silvio Danese

Humanitas University

Publications: 243

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 237

Markus M. Nöthen

Markus M. Nöthen

University Hospital Bonn

Publications: 235

Brian G. Feagan

Brian G. Feagan

University of Western Ontario

Publications: 233

Bruce M. Psaty

Bruce M. Psaty

University of Washington

Publications: 231

Joel N. Hirschhorn

Joel N. Hirschhorn

Boston Children's Hospital

Publications: 231

Nilesh J. Samani

Nilesh J. Samani

University of Leicester

Publications: 226

Something went wrong. Please try again later.